Vital Health Podcast
Claim This Podcastby Vital Health Podcast
Podcast Authority
Beta
Podcast Overview
<p>Duane Schulthess is the CEO of Vital Transformation, host and producer of Vital Health Podcast. Vital Transformation understands the implications of new medical procedures, technologies and regulations. We measure their impact upon treatment pathways and the biopharma innovation ecosystem in collaboration with health care professionals, researchers, and regulators. Through our web platform and client network, we are able to communicate our findings with international decision makers and stakeholders.</p>
Language
🇺🇲
Publishing Since
2/12/2019
Unlock The Full Podcast Authority Score Report
See how your podcast performs across key metrics
Podcast Authority
BetaRecommendations available
Unlock the full report to see detailed tips
Recommendations available
Unlock the full report to see detailed tips
Unlock comprehensive insights including:
- • YouTube presence analysis
- • Social media reach metrics
- • RSS compliance scoring
- • Podcast 2.0 features
- • Technical standards
Detailed Analytics
- Complete breakdown of all 19 authority metrics
- Personalized recommendations for each metric
- Industry benchmarks and comparisons
- Technical RSS feed analysis and compliance scoring
Growth Strategies
- Step-by-step action plans for improvement
- Quick wins to boost your score immediately
- Pro tips from successful podcasters
See how your show performs across every key metric
High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.
Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.
Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.
1 verified contact email on file for Vital Health Podcast
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
June 11, 2026
Steve Potts: Policy Headwinds Are Reshaping Biotech Financing
<p data-start="21" data-end="306">In this episode of the Vital Health Podcast, host <a href="https://www.linkedin.com/in/duane-schulthess-66ba39b7/">Duane Schulthess</a> speaks with <a href="https://www.linkedin.com/in/steven-potts/">Steve Potts</a>, CEO of <a href="https://www.linkedin.com/company/breakthrumed/">Breakthru Medicine</a>, to discuss how biotech financing, drug pricing policy, scientific infrastructure, and public trust are reshaping oncology innovation and U.S. biopharma leadership.</p> <p data-start="308" data-end="323"><strong data-start="308" data-end="323">Key Topics:</strong></p> <ul data-start="324" data-end="922"> <li data-start="324" data-end="448" data-section-id="p0uqsi"><strong data-start="326" data-end="347">Biotech Financing</strong>: Series A funding, early-stage platform headwinds, clinical asset momentum, academic funding strain.</li> <li data-start="449" data-end="573" data-section-id="k7qssb"><strong data-start="451" data-end="475">Small Molecule Shift</strong>: IRA incentives, NDA versus BLA timelines, oncology pipeline pullbacks, antibody drug conjugates.</li> <li data-start="574" data-end="686" data-section-id="1ma6irf"><strong data-start="576" data-end="595">Orphan Cures and EPIC Acts</strong>: Orphan Cures Act, EPIC Act, patent life concerns, investor return requirements.</li> <li data-start="687" data-end="807" data-section-id="11b70pc"><strong data-start="689" data-end="709">Most Favored Nation (MFN) Pricing Risk</strong>: OECD reference pricing, European access delays, launch sequencing, global cost-sharing tensions.</li> <li data-start="808" data-end="922" data-section-id="1x0h8b"><strong data-start="810" data-end="836">Science Policy Threats</strong>: NIH grant oversight, peer review risks, vaccine backlash, U.S. biopharma leadership.</li> </ul> <p>If biotech CEOs (or an executive delegate from the CEO) are interested in taking the first step toward being a policy voice on one topic in our ecosystem, contact <a href="https://www.linkedin.com/in/steven-potts/">Steve Potts on LinkedIn</a>.</p> <p>The May 29 Office of Management and Budget sweeping regulatory change, which would shift grant funding decisions from scientists to politicians, is catastrophic for science, patients, and the biotech industry. Please read about what this proposal would do, and if you agree that it would forever tie political views to winning federal funding (and it will cut both ways), please sign this petition or others and speak out: <a href="https://fight2win.standupforscience.net/">https://fight2win.standupforscience.net/</a></p> <p data-start="924" data-end="971">Opinions expressed are those of the speakers. Recorded at ASCO 2026 on 6/1/26. The Vital Health Podcast is a production of Vital Transformation LLC © 2026.</p><p>See <a href="https://omnystudio.com/listener">omnystudio.com/listener</a> for privacy information.</p>
May 13, 2026
Patrick Kelly & John Murphy: Generic Shortages and Supply Chain Risk
<p data-start="69" data-end="347">In this best-of edition of the Vital Health Podcast, we revisit two conversations <a href="https://www.linkedin.com/in/duane-schulthess-66ba39b7/">Duane Schulthess</a> has with experts on the future of generic medicines, drug shortages, and supply chain risk in the United States.</p> <ul data-start="348" data-end="502"> <li data-section-id="mlchlg" data-start="348" data-end="426"><a href="https://www.linkedin.com/in/patrick-kelly-08427a8/"><strong data-start="350" data-end="367">Patrick Kelly</strong></a>: Chief Advocacy Officer, <a href="https://www.linkedin.com/company/hdma/">Healthcare Distribution Alliance</a></li> <li data-section-id="wnfwxb" data-start="427" data-end="502"><a href="https://www.linkedin.com/in/john-murphy-iii-9b19ab1/"><strong data-start="429" data-end="444">John Murphy</strong></a>: President and CEO, <a href="https://www.linkedin.com/company/accessiblemeds/">Association for Accessible Medicines</a></li> </ul> <p data-start="504" data-end="742">Across these conversations, they discuss how low prices, thin margins, supply chain disruption, reshoring pressure, biosimilar market dynamics, insurance design, and federal pricing policy shape access to generic and biosimilar medicines.</p> <p data-start="744" data-end="759"><strong data-start="744" data-end="759">Key Topics:</strong></p> <ul data-start="760" data-end="1312"> <li data-section-id="1l363d" data-start="760" data-end="850"><strong data-start="762" data-end="783">Generic Economics</strong>: Low prices, thin margins, purchaser pressure, manufacturer exits.</li> <li data-section-id="j2s9a5" data-start="851" data-end="956"><strong data-start="853" data-end="873">Shortage Drivers</strong>: Demand spikes, facility shutdowns, sterile injectables, chemotherapy disruptions.</li> <li data-section-id="1gqfuvg" data-start="957" data-end="1083"><strong data-start="959" data-end="984">Tariffs and Reshoring</strong>: Domestic production costs, national security concerns, tariff pass-through, contract constraints.</li> <li data-section-id="1n5vcwb" data-start="1084" data-end="1199"><strong data-start="1086" data-end="1112">Biosimilar Competition</strong>: Private-label programs, vertical integration, investment uncertainty, patient access.</li> <li data-section-id="1jlakpo" data-start="1200" data-end="1312"><strong data-start="1202" data-end="1226">Policy and Insurance</strong>: IRA redesign, MFN pricing, direct-to-consumer pathways, prescription benefit reform.</li> </ul> <p data-start="1314" data-end="1361">Opinions expressed are those of the speakers. Original podcasts published in October 2025. The Vital Health Podcast is a production of Vital Transformation LLC © 2026.</p><p>See <a href="https://omnystudio.com/listener">omnystudio.com/listener</a> for privacy information.</p>
April 23, 2026
Christopher Locher: Why Vaccine Innovation Matters More Than Ever
<p>In this episode of the Vital Health Podcast, host <a href="https://www.linkedin.com/in/duane-schulthess-66ba39b7/">Duane Schulthess</a> speaks with <a href="https://www.linkedin.com/in/christopher-locher-biotech/">Christopher Locher</a>, Chief Executive Officer at <a href="https://www.linkedin.com/company/versatope/">Versatope Therapeutics</a>, about the current landscape for vaccine manufacturers and innovators. Their conversation covers vaccine platform development, financing challenges for infectious disease companies, policy and regulatory uncertainty, the public health implications of changes to childhood immunization schedules, and the steps needed to rebuild trust in vaccination.</p> <p><strong>Key Topics:</strong><br><strong></strong></p> <ul> <li><strong>Vaccine Platform Innovation:</strong> Nanoparticle technology, universal influenza vaccine development, multispecific targeting, infectious disease, and oncology applications.<br><strong></strong></li> <li><strong>Financing Challenges: </strong>Venture capital headwinds, NIH support, clinical development costs, grant cancellations, and startup survival pressures.<br><strong></strong></li> <li><strong>Policy Uncertainty:</strong> Changes to childhood immunization schedules, liability debates, academic licensing concerns, royalty proposals, and the biotech investment climate.<br><strong></strong></li> <li><strong>Public Health Risks:</strong> Vaccine access, childhood disease vulnerability, antimicrobial resistance, influenza complications, and consequences of fragmented immunization policy.<br><strong></strong></li> <li><strong>Trust Rebuilding: </strong>COVID backlash, transparency concerns, anti-science sentiment, provider-patient communication, rebuilding confidence in vaccines.</li> </ul> <p>Opinions expressed are those of the speakers.</p><p>See <a href="https://omnystudio.com/listener">omnystudio.com/listener</a> for privacy information.</p>
149 total episodes available
Similar Podcasts
Discover related shows you might enjoy
Deep-dive analytics for Vital Health Podcast
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Vital Health Podcast?
<p>Duane Schulthess is the CEO of Vital Transformation, host and producer of Vital Health Podcast. Vital Transformation understands the implications of new medical procedures, technologies and regulations. We measure their impact upon treatment pathways and the biopharma innovation ecosystem in collaboration with health care professionals, researchers, and regulators. Through our web platform and client network, we are able to communicate our findings with international decision makers and stakeholders.</p> - How often does this podcast release new episodes?
This podcast updates bi-weekly.
- Where can I listen to this podcast?
This podcast is available on 9 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
No, this podcast does not typically feature guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.